Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
This is the first update to the original CTS communication distributed on July 6th. As previously co...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...